Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

Rubidium Chloride

Unique Identifier:LAT007B08
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:ClHRb
Molecular Weight:120.921 g/mol
X log p:(online calculus)
Lipinksi Failures0
TPSA0
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:0
Rotatable Bond Count:0
Canonical Smiles:[ClH-].[Rb+]
Generic_name:Cetrorelix
Drug_type:Approved Drug
Pharmgkb_id:PA10255
Drugbank_id:APRD00686
Cas_registry_number:120287-85-6
Drug_category:Infertility Agents; Hormone Antagonists; ATC:H01CC02
Indication:For the inhibition of premature LH surges in women undergoing controlled ovarian
stimulation.
Pharmacology:Cetrorelix is a synthetic decapeptide with gonadotropin-releasing hormone (GnRH)
antagonistic activity. GnRH induces the production and release of luteinizing
hormone (LH) and follicle stimulating hormone (FSH) from the gonadotrophic cells of
the anterior pituitary. Due to a positive estradiol (E2) feedback at midcycle, GnRH
liberation is enhanced resulting in an LH-surge. This LH-surge induces the ovulation
of the dominant follicle, resumption of oocyte meiosis and subsequently
luteinization as indicated by rising progesterone levels. Cetrorelix competes with
natural GnRH for binding to membrane receptors on pituitary cells and thus controls
the release of LH and FSH in a dose-dependent manner.
Mechanism_of_action:Cetrorelix binds to the gonadotropin releasing hormone receptor and acts as a potent
inhibitor of gonadotropin secretion. It competes with natural GnRH for binding to
membrane receptors on pituitary cells and thus controls the release of LH and FSH in
a dose-dependent manner.
Organisms_affected:Humans and other mammals

Found: 5 nonactive as graph: single | with analogs << Back 1 2 3 4 5 Next >> 
Species: 4932
Condition: pdr24h
Replicates: 2
Raw OD Value: r im 0.7055±0.0226981
Normalized OD Score: sc h 0.9920±0.033205
Z-Score: -0.2637±1.4519
p-Value: 0.321208
Z-Factor: -17.3543
Fitness Defect: 1.1357
Bioactivity Statement: Nonactive
Experimental Conditions
Library:LATCA
Plate Number and Position:7|B8
Drug Concentration:50.00 nM
OD Absorbance:600 nm
Robot Temperature:27.10 Celcius
Date:2007-03-08 YYYY-MM-DD
Plate CH Control (+):0.0406±0.00244
Plate DMSO Control (-):0.6669±0.01885
Plate Z-Factor:0.9126
png
ps
pdf

DBLink | Rows returned: 4388[1] << Back 721 722 723 724 725 726 727 728 729 730  Next >> [732]
15977990 platinum; rhodium
15978228 carbanide; zirconium(+2) cation
15978248 dilithium dihydroxide
15978250 dilithium hydroxide
15978251 cadmium tetrahydrate
15980736 dipotassium mercury(+2) cation tetraiodide

internal high similarity DBLink | Rows returned: 0

active | Cluster 1 | Additional Members: 50 | Rows returned: 142 3 Next >> 
LOPAC 00756 0
SPE01503428 0
LAT007G07 0
Prest1291 0
LAT007H07 0
LAT007E08 0

Service provided by the Mike Tyers Laboratory